Bempegaldesleukin (BEMPEG) plus nivolumab (NIVO) compared to the investigatoraEUR(tm)s choice of Sunitinib or Cabozantinib in previously untreated advanced renal cell carcinoma (RCC): Results from a Phase 3 randomized study (PIVOT-09)
Bempegaldesleukin;Nivolumab;Cabozantinib;Sunitinib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Bempegaldesleukin (BEMPEG) plus nivolumab (NIVO) compared to the investigatoraEUR(tm)s choice of Sunitinib or Cabozantinib in previously untreated advanced renal cell carcinoma (RCC): Results from a Phase 3 randomized study (PIVOT-09) ### Output: Bempegaldesleukin;Nivolumab;Cabozantinib;Sunitinib